← Back to headlines
FDA Poised to Allow Compounding Pharmacies to Make Peptides, Reportedly Influenced by RFK Jr.
The FDA is reportedly ready to reverse its 2023 decision and lift restrictions on peptides, allowing compounding pharmacies to produce them, a move that the wellness world eagerly anticipates and is said to follow advocacy from RFK Jr.
31 Mar, 14:09 — 31 Mar, 17:52
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 3/5 buckets covered17/33
Far L1
Far Left (1)
NYT
Left1
Left (1)
NPR
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US3
ℹAll sources from US region
Sources
Showing 3 of 3 sources
NYTMostly Factual9d ago
FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes
The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
By Christina Jewett and Dani Blum
Read full article →NPRHigh8d ago
The wellness world is eager for RFK Jr.'s promised move on peptides
A month ago, Health Secretary Kennedy said his agency would soon give compounding pharmacies the greenlight to make the products, which have exploded in popularity despite a lack of data.
By Will Stone
Read full article →seeking-alphaMixed8d ago
FDA ready to allow compounding pharmacies to make injectable peptides - report
Read full article →Coverage Timeline
First report: NYT · 31 Mar, 14:09|Full coverage: 3 · 4h|Window: 4h
Left-leaningCenterRight-leaning
Related Stories
Calapan drug sting seizes P73,000 worth of shabu
just now
WHO warns Lebanon hospitals face critical medical supply shortages amid ongoing conflict
just now
WHO warns Lebanon hospitals face critical medical supply shortages amid ongoing conflict
just now
20 people fall ill after eating 'aloy' fish in Iloilo, Philippines
just now